Keyphrases
Neurofibromatosis Type I
100%
Neurofibromatosis Type 1 (NF-1)
100%
Optic Pathway Glioma
100%
Tumor
28%
Treatment Monitoring
14%
Tumor Growth
14%
Molecular Targets
14%
Molecular Pathways
14%
Conventional Chemotherapy
14%
Young children
14%
Genetic Engineering
14%
Cellular Pathways
14%
Treatment Plan
14%
Diplopia
14%
Neurofibromin
14%
Individualized Prediction
14%
Glioma Growth
14%
Vision Loss
14%
Early Phase Clinical Trials
14%
Treatment Optimization
14%
Visual Function
14%
Optic Nerve Injury
14%
Proptosis
14%
Cancer Predisposition Syndrome
14%
Gliomagenesis
14%
Optics
14%
Slow-growing
14%
Precocious Puberty
14%
Optic Pathway
14%
Long-term Recovery
14%
Risk Assessment Strategy
14%
Tumor Monitoring
14%
Glioma Mouse Model
14%
Glioma Diagnosis
14%
Medicine and Dentistry
Neurofibromatosis Type I
100%
Ganglioglioma
100%
Neoplasm
50%
Clinical Trial
16%
Visual Impairment
16%
Cancer Susceptibility
16%
Toddlers
16%
Tumor Progression
16%
Diplopia
16%
Exophthalmos
16%
Optic Nerve Glioma
16%
Optic Nerve Injury
16%
Vision
16%
Precocious Puberty
16%
Neurofibromin 1
16%